跳至主要内容
临床试验/NCT04928534
NCT04928534已完成不适用

Observational Cohort Study of Blood Transcriptomics and Proteomics Information as Biomarkers of Traumatic Encephalopathy Syndrome

Tianjin Medical University2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2021年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120
试验地点
2
主要终点
Blood level of novel protein biomarkers for CTE/TES

研究概览

简要总结

In this study, high-throughput screening and multi-omics (transcriptomics and proteomics) joint analysis technology will be employed to explore potential CTE/TES biomarkers (RNA and protein) in blood and its exosomes. Thereafter, these biomarkers will be combined with the reported TBI biomarkers to create a novel set of CTE/TES molecular diagnostic signatures. The findings may open a new avenue for the clinical diagnosis of the disease and the future research on its therapeutic strategy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Athletes and patients with traumatic brain injury
  • Age ≥ 18 and ≤ 80 years old with independent behavior ability or authorized legal representative.
  • Have a clear history of repetitive mild TBI, concussion or subconcussion.
  • The most recent head injury occurred 3 months ago.
  • Healthy Volunteers
  • Age ≥ 18 and ≤ 80 years old with independent behavior ability.
  • No history of repetitive mild TBI, concussion or subconcussion.
  • Fully understands the nature of the study, and voluntarily participates and signs the informed consent.

排除标准

  • Athletes and patients with traumatic brain injury
  • Pregnant or lactating women.
  • History of other neurological diseases.
  • History of tumors, hematological diseases, severe cardiopulmonary diseases, hepatic failure or renal failure.
  • Have participated in clinical trials in the past four weeks.
  • The investigator believes that not appropriate for inclusion.
  • Healthy Volunteers
  • Pregnant or lactating women.
  • History of TBI or other neurological diseases.
  • History of tumors, hematological diseases, severe cardiopulmonary diseases, hepatic failure or renal failure.
  • Have participated in clinical trials in the past four weeks.
  • The investigator believe that not appropriate for inclusion.

研究组 & 干预措施

Athletes with rmTBI history

50 active or retired athletes from the Weightlifting, Wrestling, Judo, Boxing and Taekwondo Sports Management Center of Tianjin Sports Bureau

干预措施: Blood tests, Cognitive function tests, head MRI (plain scan and DTI sequence) examination and head PET (FDG-PET, Tau-PET and Amyloid-PET) examination (Diagnostic Test)

Patients with rmTBI history

50 patients with multiple (≥2 times) exposure to brain trauma attending Tianjin Medical Insurance designated hospitals such as Tianjin Medical University General Hospital

干预措施: Blood tests, Cognitive function tests, head MRI (plain scan and DTI sequence) examination and head PET (FDG-PET, Tau-PET and Amyloid-PET) examination (Diagnostic Test)

Healthy volunteer

20 healthy volunteers

干预措施: Blood tests, Cognitive function tests, head MRI (plain scan and DTI sequence) examination and head PET (FDG-PET, Tau-PET and Amyloid-PET) examination (Diagnostic Test)

结局指标

主要结局

Blood level of novel protein biomarkers for CTE/TES

时间窗: Baseline

Novel protein biomarkers for CTE/TES will be screened out by transcriptomics + proteomics high-throughput detection and multi-omics bioinformatics analysis. Their levels will be further verified using ELISA assay.

Blood level of novel RNA biomarkers for CTE/TES

时间窗: Baseline

Novel RNA biomarkers for CTE/TES will be screened out by transcriptomics + proteomics high-throughput detection and multi-omics bioinformatics analysis. Their levels will be further verified using RT-PCR.

次要结局

  • Blood level of classical biomarkers for CTE/TES(Baseline)
  • Ultrasound examination of the carotid arteries and lower limb arteries(5 years post-enrollment)
  • Serum Treg cell count and degree of senescence(5 years post-enrollment)
  • Cognitive function tests - RPQ-3(5 years post-enrollment)
  • Cognitive function tests - RPQ-16(5 years post-enrollment)
  • Cognitive function tests - MoCA(5 years post-enrollment)
  • Cognitive function tests - MMSE(5 years post-enrollment)

研究者

发起方
Tianjin Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Xintong Ge

Principal Investigator

Tianjin Medical University General Hospital

研究点 (2)

Loading locations...

相似试验